Knee osteoarthritis (KOA) is the most common degenerative joint disease and has become a major public health challenge affecting the quality of life of middle-aged and elderly populations1. According to statistics from the World Health Organization (WHO), nearly 10% of men and 18% of women over 60 years old worldwide are affected by KOA, and its incidence is rising rapidly with the acceleration of population aging2,3. These conditions manifest through a series of clinical symptoms, such as pain, knee swelling, and functional impairment, bringing significant difficulties to patients, families, and society, while imposing a heavy economic burden4. Faced with this severe reality, although modern medicine has various approaches to the treatment of KOA, such as non-steroidal anti-inflammatory drugs (NSAIDs) to relieve pain, intra-articular injections to improve function, and ultimate joint replacement surgery, it has always been difficult to avoid multiple predicaments, including drug dependence, long-term side effects, surgical risks, and economic costs5,6. Therefore, exploring effective therapeutic strategies and drugs against KOA is a key and challenging long-term pursuit. Our goal is to identify promising pharmaceutical interventions that can hinder or improve KOA to a certain extent, while investigating the underlying mechanisms, in order to reveal new insights and methods for its management.
Traditional Chinese medicine (TCM), with a long history and documented records in ancient medical literature, is one of the oldest continuously practiced therapeutic systems7. TCM refers to the medicines used in the traditional Chinese medical system for preventing and treating diseases, which has been widely applied worldwide. It encompasses Chinese herbal medicines (including botanical, mineral, and animal-derived medicines), herbal formulas, proprietary Chinese medicines (TCM preparations), and TCM extracts. It not only demonstrates prominent efficacy in anti-inflammation and antioxidation but also further inhibits cell apoptosis through these effects while improving the body's microcirculation8,9,10. In modern pharmacological studies of TCM in KOA, it has been found that the active ingredients of Chinese medicinal herbs can exert synergistic protective effects through multiple pathways, such as inhibiting inflammatory factors, regulating cartilage metabolism, improving microcirculation, and resisting oxidative stress11,12. A large number of clinical randomized controlled trials (RCTs) have also confirmed that comprehensive TCM therapies have definite efficacy in significantly relieving pain, improving joint function, delaying disease progression, and enhancing quality of life, with generally good safety13. Currently, in the field of degenerative diseases such as KOA, where the efficacy of Western Medicine remains elusive, TCM provides new perspectives and potential new approaches.
With the vigorous development of research on TCM for the prevention and treatment of KOA, a massive amount of academic literature has shown explosive growth. However, the surge in knowledge has also brought new challenges: vague core issues, insufficient depth of interdisciplinary integration, and unclear context of knowledge inheritance and innovation have become increasingly prominent. Therefore, it is crucial to thoroughly grasp the current situation, research trends, and emerging themes in this field. Bibliometrics applies mathematical and statistical methods to quantitatively analyze the external characteristics of literature, such as the number of publications, authors, institutions, countries, journal distribution, and citation networks. Combined with content analysis, it can objectively depict the academic influence, cooperation networks, and evolution of research hotspots in specific fields14. However, comprehensive and systematic bibliometric reports specifically focusing on TCM for KOA remain limited.
This study aims to conduct a systematic, in-depth analysis of the research literature on TCM for the treatment of KOA from the Web of Science Core Collection (WOSCC) database over the past two decades, using bibliometric and visual analysis methods. By drawing the annual number of articles, country/institution collaboration networks, author co-occurrence networks, journal co-citations, literature co-citations, and keyword co-occurrence and clustering maps, we aim to conduct in-depth research on the current status, popular themes, and constantly developing trends in this field, with the aim of providing potential theoretical foundations for clinical drug development and strong evidence for the treatment of KOA.